These data showed that CDKN1A and KLF2 could inhibit proliferation of BxPC-3 cells, which was contrary to the effects of DUXAP8 downregulation in pancreatic cancer cells. This evidence concerns the gene DUXAP8 and familial pancreatic carcinoma.